• Guanabenz Acetate: A Precision Tool for Dissecting α2-Adrene

  2026-06-29

  Explore the unique capabilities of Guanabenz Acetate as a selective α2-adrenergic receptor agonist for advanced signaling and innate immunity research. This article offers a protocol-driven, mechanistic analysis distinct from existing content.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-06-29

  This study uncovers how LAMP1 governs the context-dependent effects of the CXCL10-CXCR3 axis on macrophage polarization during inflammation. By dissecting the roles of autophagy and chemokine signaling, the research provides mechanistic insight into how CXCR3 antagonists like AMG 487 differentially regulate immune responses, with implications for acute lung injury models.

• Smoothened Function in Honeybee Olfaction: Insights from Ago

  2026-06-28

  Guo et al. (2024) provide the first direct evidence that Smoothened (Smo), a core Hedgehog pathway component, modulates olfactory receptor expression and function in Apis mellifera. Their work not only expands the known roles of Smo beyond development but also demonstrates the utility of small molecule agonists and antagonists as research tools in sensory biology.

• In Silico Peptide Screening for β-Lactamase Inhibition in E.

  2026-06-27

  The referenced study introduces MDockPeP2_VS, an automated in silico platform for large-scale screening of protein-binding peptides. This method enabled the rapid discovery of potent peptide inhibitors targeting TEM-1 β-lactamase in E. coli, offering a promising approach for antibiotic resistance research and peptide drug discovery.

• Iron-Dependent KDM4D Modulates MSC Quiescence via PI3K-Akt-F

  2026-06-26

  This study uncovers how iron-dependent KDM4D demethylase activity governs the balance between quiescence and activation of mesenchymal stem cells (MSCs) through the PI3K-Akt-Foxo1 pathway. The findings establish a mechanistic link between iron metabolism, epigenetic regulation, and bone remodeling, with implications for osteoporosis and metabolic disease research.

• L-NMMA Acetate: Advanced NOS Pathway Modulation in Research

  2026-06-26

  L-NMMA acetate delivers precise and reproducible inhibition of all three nitric oxide synthase isoforms, empowering rigorous investigation of the nitric oxide pathway in regenerative and inflammation research. This in-depth guide covers practical workflows, data-driven protocol parameters, and troubleshooting insights to unlock the full potential of this gold-standard inhibitor from APExBIO.

• AMPK Inhibits Autophagy Under Energy Stress: New Mechanistic

  2026-06-25

  This study overturns the prevailing model of AMPK-driven autophagy by demonstrating that AMPK activation actually inhibits autophagy initiation during glucose starvation via suppression of ULK1. These findings reshape our understanding of metabolic stress responses and highlight new considerations for research on cellular energy homeostasis.

• In Vitro Pharmacodynamics of Gamithromycin Against MmmSC

  2026-06-25

  This study provides the first detailed analysis of Gamithromycin's in vitro activity against Mycoplasma mycoides subspecies mycoides Small Colony (MmmSC), the causative agent of contagious bovine pleuropneumonia. Findings clarify the antibiotic's potency in serum versus artificial media and benchmark its efficacy against established macrolides, informing rational therapeutic strategies for challenging veterinary pathogens.

• 6-Thioguanine Suppresses EV71 via BIRC3-Mediated Autophagy I

  2026-06-24

  You et al. (2025) reveal that 6-thioguanine potently inhibits Enterovirus 71 (EV71) replication in vitro by targeting BIRC3-mediated autophagy. This mechanistic advance highlights a new antiviral application for an established antineoplastic agent, supporting the exploration of cross-domain therapeutic strategies.

• LAMP1 Modulates CXCL10-CXCR3 Axis in Macrophage Polarization

  2026-06-23

  This study uncovers how LAMP1 acts as a molecular switch in the CXCL10-CXCR3 axis, dictating macrophage polarization differently in inflammatory versus non-inflammatory states. The work establishes context-specific roles for CXCR3 antagonists like AMG 487 and highlights new therapeutic directions for acute lung injury and inflammation research.

• Age-Related CMA Decline Drives Myopathy via Proteostasis Fai

  2026-06-23

  This study demonstrates that chaperone-mediated autophagy (CMA) is crucial for maintaining skeletal muscle function and that its decline with age leads to progressive myopathy. By employing muscle-specific CMA-deficient mice and proteomic analyses, the research reveals impaired calcium homeostasis and identifies SERCA as a key CMA substrate, highlighting new targets for muscle aging intervention.

• GSK-923295: Illuminating CENP-E Inhibition and Centromere Dy

  2026-06-22

  Explore how GSK-923295, a potent CENP-E inhibitor, uniquely advances cancer research by dissecting centromere dynamics and mitotic cell cycle arrest. This article provides in-depth analysis, protocol insights, and a critical synthesis of recent centromere function discoveries.

• Smoothened Modulation and Olfactory Function in Honeybees

  2026-06-22

  Guo et al. (2024) present the first detailed characterization of Smoothened (Smo) in Apis mellifera, revealing its key role in regulating olfactory receptor expression and sensory behavior. The study demonstrates that pharmacological activation of Smo, notably using Purmorphamine, enhances specific olfactory-driven behaviors, providing a new molecular framework for insect sensory research.

• Panobinostat-Induced Calcineurin Degradation in Multiple Mye

  2026-06-21

  This study uncovers a novel mechanism in which the histone deacetylase inhibitor panobinostat promotes degradation of calcineurin (PPP3CA) in multiple myeloma (MM) cells, enhancing therapeutic efficacy, especially in bortezomib-resistant disease. The findings highlight a new molecular vulnerability in MM and inform future strategies for combinatorial epigenetic therapies.

• JNJ-26854165 (Serdemetan): HDM2 Antagonist Benchmarks in Can

  2026-06-20

  JNJ-26854165 (Serdemetan) is a targeted HDM2 ubiquitin ligase antagonist that stabilizes p53 and induces apoptosis in p53 wild-type tumor models. It demonstrates potent anti-proliferative effects and radiosensitization, with rigorously characterized in vitro and in vivo benchmarks. This article details its mechanisms, evidence base, and integration into advanced cancer research workflows.

451 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page